Bakker Juliet Tammenoms

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: RxSight Inc., 3 years.

RxSight Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 6, 2024 RxSight Inc. Grant or award +2,554 โ€” โ€”
May 17, 2024 RxSight Inc. Open-market purchase +5,000 $61.09 $305,450
Feb 14, 2024 RxSight Inc. Open-market purchase +4,000 $51.29 $205,160
Feb 12, 2024 RxSight Inc. Open-market purchase +4,000 $50.38 $201,520
Nov 30, 2023 RxSight Inc. Other โˆ’445,400 โ€” โ€”
Nov 30, 2023 RxSight Inc. Other +693 โ€” โ€”
Nov 30, 2023 RxSight Inc. Other +1,617 โ€” โ€”
Nov 29, 2023 RxSight Inc. Open-market sale โˆ’349,245 $29.77 $10,397,024
Nov 28, 2023 RxSight Inc. Open-market sale โˆ’145,068 $29.62 $4,296,914
Nov 15, 2023 RxSight Inc. Open-market sale โˆ’400,000 $27.20 $10,880,000
Nov 14, 2023 RxSight Inc. Open-market sale โˆ’100,000 $27.13 $2,713,000
Sep 11, 2023 RxSight Inc. Open-market sale โˆ’2,950 $30.01 $88,530
Sep 8, 2023 RxSight Inc. Open-market sale โˆ’10,033 $30.25 $303,498
Sep 7, 2023 RxSight Inc. Open-market sale โˆ’19,967 $30.10 $601,007
Aug 25, 2023 RxSight Inc. Open-market sale โˆ’16,208 $29.25 $474,084

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.